For patients interested in AOD-9604 for joint health, the clinical team evaluates joint symptoms, activity level, medical history, and overall health goals to determine candidacy
Products are not intended for administration to humans or animals and are not presented as having any medical, diagnostic, therapeutic, or clinical purpose
Still, its difficult to know just how many people are using peptide therapy today
The lack of robust BPC-157 human trialsspecifically Phase II and Phase III studiesmeans that definitive conclusions about its efficacy, optimal dosing, and long-term safety in humans cannot be made
Digestive System Regeneration BPC, Body Protective Compound, was originally researched for digestive applications, and BPC-157 demonstrates remarkable healing properties throughout the gastrointestinal tract